T0	Participants 13 79	rheumatoid arthritis patients treated with etanercept monotherapy:
T1	Participants 343 402	etanercept-treated patients with rheumatoid arthritis (RA).
T2	Participants 411 630	Data from an RCT (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes [TEMPO]; n=682) and an observational registry (Rheumatoid Arthritis DMARD Intervention and Utilization Study [RADIUS II]; n=4341)
T3	Participants 730 796	patients initiating etanercept (monotherapy or with methotrexate).
T4	Participants 958 1035	RESULTS Patients from TEMPO and RADIUS II who received etanercept monotherapy
T5	Participants 1394 1439	more patients with lower baseline CDAI scores